Condition
IBM
Total Trials
3
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07823101RecruitingPrimary
Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
NCT07374107RecruitingPrimary
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
NCT03633318CompletedPrimary
Establishing Muscle Impedance Parameters With Electrical Impedance Myography
Showing all 3 trials